Related Experiment Video
Updated: Jul 20, 2026
Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning
Published on: February 17, 2016
Reinforcing the evidence of oligoclonal bands as a prognostic factor in patients with Multiple sclerosis
G Ben Noon1, I Vigiser2, T Shiner3
1Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Abstract:
The prognostic value of oligoclonal bands in the cerebrospinal fluid of Multiple Sclerosis (MS) patients is controversial. While several studies have demonstrated a worse disease course in OCB positive patients, others did not reproduce these findings. We evaluated the prognostic significance of OCB retrospectively based on clinical records of OCB status upon diagnosis and severity outcomes including the MS Severity Score, Progression Index and regional involvement in Magnetic Resonance Imaging. OCB positive patients had a higher median MSSS and PI, and a greater proportion of spinal cord involvement. These findings provide further evidence of the prognostic importance of OCB in MS patients.
Insights
Oligoclonal bands (OCB) in cerebrospinal fluid may predict a worse Multiple Sclerosis (MS) disease course. OCB-positive MS patients showed higher severity scores and more spinal cord involvement, supporting OCB
Area of Science:
- Neurology
- Neuroimmunology
- Biomarker Research
Background:
- The prognostic value of oligoclonal bands (OCB) in cerebrospinal fluid (CSF) for Multiple Sclerosis (MS) patients remains debated.
- Conflicting study results highlight the need for further investigation into OCB's predictive significance in MS.
- This study retrospectively analyzes OCB status at diagnosis against long-term disease severity outcomes in MS.
Discussion:
- OCB positivity in MS patients correlates with increased disease severity, as indicated by higher MS Severity Score (MSSS) and Progression Index (PI).
- A greater proportion of OCB-positive patients exhibited spinal cord involvement, suggesting a link between OCB and specific lesion patterns.
- These findings address the controversy by providing robust evidence for OCB's prognostic utility in MS.
Key Insights:
- OCB in CSF is a significant prognostic marker in Multiple Sclerosis.
- Patients with OCB demonstrate a more severe disease trajectory and increased likelihood of spinal cord lesions.
- This research reinforces the clinical relevance of OCB testing for MS patient management.
Outlook:
- Further research should explore the underlying biological mechanisms linking OCB to MS progression.
- Investigating OCB's role in predicting response to disease-modifying therapies could refine treatment strategies.
- Longitudinal studies incorporating advanced imaging and genetic data will further elucidate OCB's prognostic power.
